Pharmaceuticals Insights- Page 4 of 4

Oral solid dose tablets on a continuous manufacturing line

Continuous OSD manufacturing—a technology update

Continuous oral solid dosage manufacturing is a transformational processing platform that is here today and is here to stay. Although the industry is working on harmonization and some level of standardization of the platforms, continuous manufacturing is not a one-size-fits all offering.

Closing the deal: Understanding when to close your process

When to close your pharmaceutical process

Too often, the term “closed process” is thrown around without an understanding of the salient issues. Pharmaceutical process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.

Can’t hack it? Why pharma should heed the growing threats to cyber security

Cybersecurity considerations for pharmaceutical companies

Who would want to hack a programmable logic controller? Is cybersecurity really that important for pharma companies?

Continuous OSD manufacturing and patient impact

FDA approved oral solid dosage (OSD) products are improving, changing and enhancing lives, via the use of a continuous manufacturing platform.

Solving biopharma design challenges with computational fluid dynamics

Computational fluid dynamics and cloud computing can make complex models more cost-effective and less time-consuming.

Passing through the barrier

Over the past decade, aseptic filling isolators have improved patient safety by use of barriers to isolate the point of filling from personnel. This industry-wide movement creates opportunities to further increase patient safety by minimizing viable and nonviable risks to the aseptic fill.

Strip the strip curtains in aseptic cleanrooms

Like most things, improvement happens naturally over time with the application of knowledge and the advancement of technology. This is particularly true for aseptic cleanrooms and even more so with respect to strip curtains. As cleanroom technology has evolved, we’ve developed a better understanding of how to—and how not to—maintain an aseptic environment.

To outsource or not to outsource? That is the question: How to ensure your CMO stacks up

How to choose a contract manufacturing organization

The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.

Designing an OSD facility to protect drug products

Protecting OSD drug products from contamination during manufacturing is vitally important. Here’s how facility design can help. *As appeared in Tablets & Capsules – Solid Dose Digest, July 10, 2017

Building a thoughtful manufacturing supply chain

In the past 5 years, the biopharmaceutical industry has seen unprecedented change. Precipitated by the need to support a global client base with products that are more targeted, efficacious and cost-effective, the challenge to have a robust manufacturing supply chain is more crucial than ever to a company’s survival.